Significance of viability assessment
Left ventricular dysfunction in chronic coronary artery disease (CAD) can be caused by various factors. Histologically, the myocardium may be nonviable (necrosis or scar tissue replacement) or viable (isomeric, stunned [stunned], or hibernating [hibernating]).
Restoration of blood flow (revascularization) in viable segments leads to significant improvements:
- Regional and global contractility are restored.
- Adverse cardiac remodeling is halted.
- Symptoms of heart failure are reduced.
- Patient survival and exercise tolerance are increased.
Note: The term "hibernating myocardium" is applied retrospectively to dysfunctional tissue that regains function after surgery, as cellular dedifferentiation has not been reliably proven.
Main imaging approaches
None of the existing methods guarantee 100% predictive accuracy; therefore, clinical practice relies on multiple criteria:
- Myocardial wall thickness. End-diastolic thickness is evaluated (normal for prognosis is >5.5–6 mm). However, not all thickened segments recover, and thinned ones can sometimes improve function.
- Cell membrane integrity. Assessed using SPECT (radiopharmaceutical uptake) or contrast-enhanced MRI. The viability threshold is typically set at >50% tracer uptake relative to healthy tissue.
- Extracellular space volume (scarring). Late gadolinium enhancement MRI (LGE-CMR) is the gold standard for scar detection. If no scar is present, improvement occurs in 78% of cases. If the scar is transmural (involving >75% of the wall), the chance of recovery is only 2%.
- Myocardial metabolism. PET is used to assess perfusion (e.g., with $13N$-ammonia) and glucose uptake ($18F$-FDG). The presence of metabolism in the setting of reduced blood flow (mismatch) indicates viability.
Instrumental diagnostic methods
Several modalities are used to determine viability:
- Cardiovascular MRI (CMR). Allows assessment of wall thickness, edema (on $T2$-weighted images), microvascular obstruction, and the presence of a scar. For borderline cases (scar in 25–75% of the wall), adding stress tests is useful.
- PET (PET). Has high sensitivity (approximately 90%) and allows quantitative assessment of blood flow and metabolism. Disadvantages include high cost and limited availability.
- Stress echocardiography / Dobutamine stress CMR. Detects contractile reserve. Viable myocardium responds to low doses of dobutamine with improved contractility (often followed by worsening at high doses—a biphasic response).
- SPECT (SPECT). Evaluates tracer uptake, but is limited by low spatial resolution, which may cause small subendocardial infarctions to be missed.
Briefly: answers to topical questions
Which radiopharmaceuticals are used in PET to assess myocardial perfusion and metabolism?
Two main tracers are used to assess myocardial perfusion and metabolism with PET. Perfusion is evaluated using ammonia (NH3, 13N-ammonia), and myocardial metabolism is evaluated using fluorodeoxyglucose (18F-FDG, 18F-fluorodeoxyglucose). The coincidence of an NH3 perfusion defect and absent FDG metabolism (a "match" pattern) indicates irreversibly injured, nonviable myocardium, whereas a mismatch between reduced blood flow and preserved FDG uptake indicates viability.
What are the disadvantages of SPECT in assessing myocardial viability?
The main disadvantage of SPECT in assessing myocardial viability is its low spatial resolution (about 7 mm), which limits the detection of subendocardial infarctions. Furthermore, compared to PET, SPECT has lower spatial resolution, higher radiation exposure, and does not allow for absolute quantitative assessment of myocardial blood flow—advantages that PET specifically offers.
What radiopharmaceuticals are used for myocardial SPECT?
Thallium-201 (201Tl), technetium-99m (99mTc) sestamibi (MIBI), and technetium-99m tetrofosmin are used for myocardial SPECT.
What are the contraindications for gadolinium-enhanced cardiac MRI?
The sources do not explicitly list contraindications for gadolinium-enhanced cardiac MRI, but they note that in severe renal failure, gadolinium is associated with the development of nephrogenic systemic fibrosis (NSF), so contrast is strictly avoided in such cases. The risk of gadolinium deposition in the basal ganglia is also noted, although no clinical consequences of this phenomenon have been identified.
Class and exam questions
What is a PET mismatch pattern?
This is a perfusion-metabolism mismatch: reduced blood flow with preserved $18F$-fluorodeoxyglucose uptake. This is a classic sign of viable yet ischemic myocardium.
How does scar depth on MRI affect recovery prognosis?
The greater the transmurality of the scar (gadolinium enhancement), the lower the chance of functional recovery after revascularization. When more than 75% of the wall thickness is affected, functional improvement is virtually impossible.
Why is dobutamine stress echocardiography important?
It allows for the assessment of contractile reserve. If a dysfunctional segment begins to contract in response to low doses of the drug, it confirms its viability.
What else to study on this topic
- MRI findings in acute myocardial infarction and microvascular obstruction
- Extracellular volume (ECV) calculation and T1/T2 mapping
- Differential diagnosis of MINOCA (MI, myocarditis, Takotsubo cardiomyopathy)
- Imaging for cardiac resynchronization therapy (CRT) planning
- MRI evaluation of CAD complications: thrombosis, aneurysms, myocardial rupture
Master the entire topic in the "Diagnostic Radiology" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Assessment of Myocardial Viability" and 2,199 other subjects
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 10 video lessons on the subject
Other topics in the «Chest Radiology» section
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.